SE9904651D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE9904651D0
SE9904651D0 SE9904651A SE9904651A SE9904651D0 SE 9904651 D0 SE9904651 D0 SE 9904651D0 SE 9904651 A SE9904651 A SE 9904651A SE 9904651 A SE9904651 A SE 9904651A SE 9904651 D0 SE9904651 D0 SE 9904651D0
Authority
SE
Sweden
Prior art keywords
novel compounds
novel
compounds
Prior art date
Application number
SE9904651A
Other languages
Swedish (sv)
Inventor
Lilian Alcaraz
Mark Furber
Timothy Luker
Michael Moretime
Philip Thorne
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9904651A priority Critical patent/SE9904651D0/en
Publication of SE9904651D0 publication Critical patent/SE9904651D0/en
Priority to TW089125761A priority patent/TWI258462B/en
Priority to EP03013991A priority patent/EP1352897B1/en
Priority to ES03013989T priority patent/ES2282546T3/en
Priority to PT00986155T priority patent/PT1242364E/en
Priority to CO00094336A priority patent/CO5251381A1/en
Priority to EP00986155A priority patent/EP1242364B1/en
Priority to ES03013990T priority patent/ES2294219T3/en
Priority to EEP200200330A priority patent/EE05134B1/en
Priority to MXPA02005789A priority patent/MXPA02005789A/en
Priority to CA2393352A priority patent/CA2393352C/en
Priority to ES03013991T priority patent/ES2279031T3/en
Priority to AT03013991T priority patent/ATE350364T1/en
Priority to SK841-2002A priority patent/SK286987B6/en
Priority to KR1020077000596A priority patent/KR20070012883A/en
Priority to DK03013991T priority patent/DK1352897T3/en
Priority to HU0300616A priority patent/HUP0300616A3/en
Priority to CZ20022093A priority patent/CZ20022093A3/en
Priority to EP03013990A priority patent/EP1352896B1/en
Priority to EP07014968A priority patent/EP1862451A1/en
Priority to DK03013989T priority patent/DK1352895T3/en
Priority to AT03013990T priority patent/ATE376994T1/en
Priority to AT00986155T priority patent/ATE261933T1/en
Priority to SI200030973T priority patent/SI1352896T1/en
Priority to RU2002119010/04A priority patent/RU2272025C2/en
Priority to AT03013989T priority patent/ATE358117T1/en
Priority to DK00986155T priority patent/DK1242364T3/en
Priority to IL15012400A priority patent/IL150124A0/en
Priority to DE60036968T priority patent/DE60036968T2/en
Priority to PL355913A priority patent/PL200836B1/en
Priority to US10/149,549 priority patent/US6881754B2/en
Priority to DE60009147T priority patent/DE60009147T2/en
Priority to ES00986155T priority patent/ES2215777T3/en
Priority to BRPI0016395A priority patent/BRPI0016395B8/en
Priority to SI200030934T priority patent/SI1352897T1/en
Priority to DE60032823T priority patent/DE60032823T2/en
Priority to SI200030383T priority patent/SI1242364T1/en
Priority to SI200030950T priority patent/SI1352895T1/en
Priority to PT03013990T priority patent/PT1352896E/en
Priority to JP2001545259A priority patent/JP3710418B2/en
Priority to TR2004/01432T priority patent/TR200401432T4/en
Priority to CNB008189226A priority patent/CN1312120C/en
Priority to PCT/SE2000/002505 priority patent/WO2001044170A1/en
Priority to KR1020027007702A priority patent/KR100710110B1/en
Priority to EP03013989A priority patent/EP1352895B1/en
Priority to NZ519378A priority patent/NZ519378A/en
Priority to AU22444/01A priority patent/AU780506B2/en
Priority to DK03013990T priority patent/DK1352896T3/en
Priority to DE60034155T priority patent/DE60034155T2/en
Priority to PT03013991T priority patent/PT1352897E/en
Priority to PT03013989T priority patent/PT1352895E/en
Priority to ARP000106695A priority patent/AR035325A1/en
Priority to MYPI20005926A priority patent/MY125978A/en
Priority to ZA200204125A priority patent/ZA200204125B/en
Priority to IS6406A priority patent/IS2246B/en
Priority to NO20022856A priority patent/NO328682B1/en
Priority to HK02108164.1A priority patent/HK1046678B/en
Priority to HK03109398A priority patent/HK1057035A1/en
Priority to HK03109399A priority patent/HK1057036A1/en
Priority to HK03109348A priority patent/HK1057034A1/en
Priority to US10/813,426 priority patent/US7132457B2/en
Priority to AU2005202321A priority patent/AU2005202321B2/en
Priority to JP2005163710A priority patent/JP2005320340A/en
Priority to US11/529,746 priority patent/US7297818B2/en
Priority to CY20071100312T priority patent/CY1106357T1/en
Priority to CY20071100671T priority patent/CY1106602T1/en
Priority to US11/812,673 priority patent/US20080139636A1/en
Priority to CY20071101609T priority patent/CY1107838T1/en
Priority to IL189758A priority patent/IL189758A0/en
Priority to US12/314,156 priority patent/US20090176853A1/en

Links

SE9904651A 1999-12-17 1999-12-17 Novel compounds SE9904651D0 (en)

Priority Applications (70)

Application Number Priority Date Filing Date Title
SE9904651A SE9904651D0 (en) 1999-12-17 1999-12-17 Novel compounds
TW089125761A TWI258462B (en) 1999-12-17 2000-12-04 Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same
EP03013991A EP1352897B1 (en) 1999-12-17 2000-12-12 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
ES03013989T ES2282546T3 (en) 1999-12-17 2000-12-12 ADAMANTAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY, IMMUNE AND CARDIOVASCULAR DISEASES.
PT00986155T PT1242364E (en) 1999-12-17 2000-12-12 ADAMANTAN DERIVATIVES
CO00094336A CO5251381A1 (en) 1999-12-17 2000-12-12 ADAMANTAN DERIVATIVES, A PROCESS FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP00986155A EP1242364B1 (en) 1999-12-17 2000-12-12 Adamantane derivatives
ES03013990T ES2294219T3 (en) 1999-12-17 2000-12-12 ADAMANTAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY, IMMUNE AND CARDIOVASCULAR DISEASES.
EEP200200330A EE05134B1 (en) 1999-12-17 2000-12-12 Adamantane derivatives, a process for their preparation, pharmaceutical compositions containing them and their use in therapy
MXPA02005789A MXPA02005789A (en) 1999-12-17 2000-12-12 Adamantane derivatives.
CA2393352A CA2393352C (en) 1999-12-17 2000-12-12 Adamantane derivatives
ES03013991T ES2279031T3 (en) 1999-12-17 2000-12-12 ADAMANTAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY, IMMUNE AND CARDIOVASCULAR DISEASES.
AT03013991T ATE350364T1 (en) 1999-12-17 2000-12-12 ADAMANTAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND CARDIOVASCULAR DISEASES
SK841-2002A SK286987B6 (en) 1999-12-17 2000-12-12 Adamantane derivatives, method for the production thereof, pharmaceutical compositions containg said compounds and method for production said compositions and their use
KR1020077000596A KR20070012883A (en) 1999-12-17 2000-12-12 Pharmaceutical compositions containing adamantane derivatives
DK03013991T DK1352897T3 (en) 1999-12-17 2000-12-12 Adamantan derivatives for the treatment of inflammatory, immune and cardiovascular diseases
HU0300616A HUP0300616A3 (en) 1999-12-17 2000-12-12 Adamantane derivatives, process for their preparation, their use and pharmaceutical compositions containing them
CZ20022093A CZ20022093A3 (en) 1999-12-17 2000-12-12 Adamantane derivatives
EP03013990A EP1352896B1 (en) 1999-12-17 2000-12-12 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
EP07014968A EP1862451A1 (en) 1999-12-17 2000-12-12 Adamantane derivatives for the treatment of inflammatory diseases
DK03013989T DK1352895T3 (en) 1999-12-17 2000-12-12 Adamantan derivatives for the treatment of inflammatory immunological and cardiovascular diseases
AT03013990T ATE376994T1 (en) 1999-12-17 2000-12-12 ADAMANTAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND CARDIOVASCULAR DISEASES
AT00986155T ATE261933T1 (en) 1999-12-17 2000-12-12 ADMANTANE DERIVATIVES
SI200030973T SI1352896T1 (en) 1999-12-17 2000-12-12 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
RU2002119010/04A RU2272025C2 (en) 1999-12-17 2000-12-12 Derivatives of adamantane, methods for their preparing, pharmaceutical composition based on thereof and method for its preparing, methods for treatment of rheumatic arthritis and lung chronic obstructive disease
AT03013989T ATE358117T1 (en) 1999-12-17 2000-12-12 ADAMANTAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND CARDIOVASCULAR DISEASES
DK00986155T DK1242364T3 (en) 1999-12-17 2000-12-12 adamantane
IL15012400A IL150124A0 (en) 1999-12-17 2000-12-12 Adamantane derivatives
DE60036968T DE60036968T2 (en) 1999-12-17 2000-12-12 Adamantane derivatives for the treatment of inflammatory, immunological and cardiovascular diseases
PL355913A PL200836B1 (en) 1999-12-17 2000-12-12 Adamantane derivatives
US10/149,549 US6881754B2 (en) 1999-12-17 2000-12-12 Adamantane derivatives
DE60009147T DE60009147T2 (en) 1999-12-17 2000-12-12 ADMANTAN DERIVATIVES
ES00986155T ES2215777T3 (en) 1999-12-17 2000-12-12 ADAMANTAN DERIVATIVES.
BRPI0016395A BRPI0016395B8 (en) 1999-12-17 2000-12-12 adamantane derivatives
SI200030934T SI1352897T1 (en) 1999-12-17 2000-12-12 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
DE60032823T DE60032823T2 (en) 1999-12-17 2000-12-12 Adamantane derivatives for the treatment of inflammatory, immunological and cardiovascular diseases
SI200030383T SI1242364T1 (en) 1999-12-17 2000-12-12 Adamantane derivatives
SI200030950T SI1352895T1 (en) 1999-12-17 2000-12-12 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
PT03013990T PT1352896E (en) 1999-12-17 2000-12-12 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
JP2001545259A JP3710418B2 (en) 1999-12-17 2000-12-12 Adamantane derivatives
TR2004/01432T TR200401432T4 (en) 1999-12-17 2000-12-12 Admanthan derivatives
CNB008189226A CN1312120C (en) 1999-12-17 2000-12-12 Adamantane derivatives
PCT/SE2000/002505 WO2001044170A1 (en) 1999-12-17 2000-12-12 Adamantane derivatives
KR1020027007702A KR100710110B1 (en) 1999-12-17 2000-12-12 Adamantane Derivatives
EP03013989A EP1352895B1 (en) 1999-12-17 2000-12-12 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
NZ519378A NZ519378A (en) 1999-12-17 2000-12-12 Adamantane derivatives
AU22444/01A AU780506B2 (en) 1999-12-17 2000-12-12 Adamantane derivatives
DK03013990T DK1352896T3 (en) 1999-12-17 2000-12-12 Adamantan derivatives for the treatment of inflammatory, immune and cardiovascular diseases
DE60034155T DE60034155T2 (en) 1999-12-17 2000-12-12 Adamantane derivatives for the treatment of inflammatory, immunological and cardiovascular diseases
PT03013991T PT1352897E (en) 1999-12-17 2000-12-12 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
PT03013989T PT1352895E (en) 1999-12-17 2000-12-12 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
ARP000106695A AR035325A1 (en) 1999-12-17 2000-12-15 ADAMANTAN DERIVATIVES, A PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION, A PROCESS FOR THE PREPARATION OF SUCH COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
MYPI20005926A MY125978A (en) 1999-12-17 2000-12-15 Admantane derivatives
ZA200204125A ZA200204125B (en) 1999-12-17 2002-05-23 Adamantane derivatives.
IS6406A IS2246B (en) 1999-12-17 2002-05-31 Adamantane derivatives
NO20022856A NO328682B1 (en) 1999-12-17 2002-06-14 Adamtan derivatives, processes for their preparation, and their use in therapy, as well as a pharmaceutical composition containing such derivatives
HK02108164.1A HK1046678B (en) 1999-12-17 2002-11-11 Adamantane derivatives
HK03109398A HK1057035A1 (en) 1999-12-17 2002-11-11 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
HK03109399A HK1057036A1 (en) 1999-12-17 2002-11-11 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
HK03109348A HK1057034A1 (en) 1999-12-17 2002-11-11 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
US10/813,426 US7132457B2 (en) 1999-12-17 2004-03-31 Adamantane derivatives
AU2005202321A AU2005202321B2 (en) 1999-12-17 2005-05-27 Adamantane derivatives
JP2005163710A JP2005320340A (en) 1999-12-17 2005-06-03 Adamantane derivative
US11/529,746 US7297818B2 (en) 1999-12-17 2006-09-29 Adamantane derivatives
CY20071100312T CY1106357T1 (en) 1999-12-17 2007-03-06 ADAMANTANIUM DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY, IMMUNE AND CARDIOVASCULAR DISEASES
CY20071100671T CY1106602T1 (en) 1999-12-17 2007-05-17 ADAMANTANIUM DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY, IMMUNE AND CARDIOVASCULAR DISEASES
US11/812,673 US20080139636A1 (en) 1999-12-17 2007-06-20 Adamantane derivatives
CY20071101609T CY1107838T1 (en) 1999-12-17 2007-12-19 ADAMANTANIUM PRODUCTION FOR THE TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND CARDIOGRAPHIC DISEASES
IL189758A IL189758A0 (en) 1999-12-17 2008-02-25 Adamantane derivatives
US12/314,156 US20090176853A1 (en) 1999-12-17 2008-12-04 Adamantane derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904651A SE9904651D0 (en) 1999-12-17 1999-12-17 Novel compounds

Publications (1)

Publication Number Publication Date
SE9904651D0 true SE9904651D0 (en) 1999-12-17

Family

ID=20418187

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904651A SE9904651D0 (en) 1999-12-17 1999-12-17 Novel compounds

Country Status (2)

Country Link
SE (1) SE9904651D0 (en)
ZA (1) ZA200204125B (en)

Also Published As

Publication number Publication date
ZA200204125B (en) 2003-08-25

Similar Documents

Publication Publication Date Title
EE200100502A (en) Compounds
PT1202994E (en) NEW COMPOUNDS
EE200200224A (en) Novel compounds
NO20016115L (en) Substituted heterocycle-condensed gamma-carboline
PT1224180E (en) SUBSTITUTED AZOIS
IS6139A (en) New compounds
ID29533A (en) CALSILITIC COMPOUNDS
NO20020466L (en) Calcilitic compounds
IS6141A (en) New compounds
NO20014262D0 (en) Tiazoloindolinon compounds
NO20022927D0 (en) Substituted pyrrazoles
DK1200423T3 (en) Substituted pehnyluracils
ID29984A (en) BIS-STIRILBIFENIL COMPOUNDS
NO991585D0 (en) Trekka scheme
SE9901118D0 (en) Novel compounds
SE9901270D0 (en) Novel compounds
SE9901078D0 (en) Novel compounds
SE9904651D0 (en) Novel compounds
SE9901117D0 (en) Novel compounds
SE9902764D0 (en) Novel compounds
SE9902194D0 (en) Novel compounds
SE9903838D0 (en) Novel compounds
SE9903080D0 (en) Novel compounds
SE9901271D0 (en) Novel compounds
SE9902903D0 (en) Novel compounds